1620 Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$108K Hold
842
0.07% 245
2026
Q1
$101K Hold
842
0.07% 234
2025
Q4
$88.6K Hold
842
0.06% 249
2025
Q3
$70.7K Hold
842
0.05% 263
2025
Q2
$66.7K Sell
842
-42
-5% -$3.34K 0.05% 277
2025
Q1
$79.4K Hold
884
0.06% 242
2024
Q4
$88K Buy
884
+1
+0.1% +$103 0.07% 242
2024
Q3
$100K Buy
883
+20
+2% +$2.38K 0.07% 224
2024
Q2
$107K Buy
+863
New +$111K 0.08% 210

Other funds holding MRK

1620 Investment Advisors's MRK Position: Q2 2026 in Review

1620 Investment Advisors held its Merck (MRK) position steady in Q2 2026 at 842 shares worth $108K. The position accounts for 0.07% of the portfolio, ranked #245.

1620 Investment Advisors first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • 1620 Investment Advisors held 842 shares of Merck worth $108K as of Q2 2026.
  • 1620 Investment Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.07% of 1620 Investment Advisors's portfolio in Q2 2026, its #245 holding.
  • 1620 Investment Advisors first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.